Guardant Health Inc is a pioneer in precision oncology, offering a wide range of blood and tissue tests to support cancer diagnosis and treatment. With products like Guardant360 and GuardantOMNI, the company focuses on providing detailed insights into cancer evolution and treatment resistance. It also offers software solutions like GuardantConnect for linking patients to clinical studies, and Guardant Galaxy, an AI-driven platform for enhancing biomarker detection. Partnering with Illumina, Inc., Guardant Health is at the forefront of cancer research, leveraging its advanced technologies to improve patient outcomes. Founded in 2011, its headquarters are in Palo Alto, California.